ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1075

The Impact of an Integrated Care Management Program on Acute Care Use for Potentially Avoidable Conditions Among High-Risk Patients with SLE

Jessica Williams1, Kreager Taber1, Weixing Huang1, Jamie Collins1, Rebecca Cunningham1, Katherine Concannon1, Christine Vogeli2, Lisa Wichmann1 and Candace Feldman1, 1Brigham and Women's Hospital, Boston, MA, 2Massachusetts General Hospital, Boston, MA

Meeting: ACR Convergence 2021

Keywords: Access to care, Health Services Research, Nursing, quality of care, Systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: Health Services Research Poster II: Care Models and Innovation (1061–1082)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: Patients with SLE are disproportionately from populations with lower socioeconomic status and poorer access to health care, placing them at risk for potentially avoidable acute care use (emergency department [ED] visits and hospitalizations that could be avoided if high-quality outpatient care were provided). We defined potentially avoidable acute care conditions using the Agency for Healthcare Research and Quality’s 10 prevention quality indicators for adults and a recently published set of 25 SLE-specific, ambulatory care-sensitive outcomes1 (Table 1). A nurse-led, primary care-based integrated care management program (iCMP) at our multihospital system coordinates care for patients at high-risk for frequent acute care use due to comorbidities, demographics, and prior use patterns. We studied whether iCMP was effective at decreasing rates of potentially avoidable ED visits and hospitalizations among patients with SLE.

Methods:
We identified adults with SLE enrolled in iCMP from January 2012-February 2019. We then used electronic health record (EHR) data linked to insurance claims to compare incidence rates of potentially avoidable ED visits (composite variable and individual conditions) and potentially avoidable hospitalizations (composite variable and individual conditions) during iCMP enrollment vs. during the 12-months prior to iCMP enrollment. We used Poisson regression to compare incidence rate ratios (IRR) during iCMP versus pre-iCMP for each utilization measure, adjusted for age, sex, race/ethnicity, number of comorbidities, and calendar year, accounting for within-patient clustering. All upper gastrointestinal (GI) bleeds and osteoporotic fractures were considered potentially avoidable as we did not have information about whether patients were taking GI protectants or osteoporosis therapy.

Results: We identified 67 iCMP enrollees with SLE and linked EHR-claims data. Sixty-one of 67 met 1997 ACR criteria for SLE; 4 met 2012 SLICC criteria and 2 did not meet criteria but were diagnosed by a rheumatologist. The mean age was 60 years; 93% were female, 55% were white, 25% Black, 16% other race, and 3% Asian; 21% were Latinx. Median iCMP enrollment time was 33 months. During iCMP enrollment, there was a decrease in the overall rate of potentially avoidable ED visits (IRR 0.50; 95% CI 0.28-0.88; see Table 2) and potentially avoidable hospitalizations (IRR 0.37; 95% CI 0.21-0.65; see Table 3). We also found that during iCMP enrollment, there was an increase in the rate of ED visits for upper GI bleed (IRR 1.28; 95% CI 1.15-1.42).

Conclusion: We found that a nurse-led, primary care-based integrated care management program is effective at decreasing the rate of potentially avoidable ED visits and hospitalizations among high-risk SLE patients. We hypothesize that this is due to optimization of outpatient care. ED visits for upper GI bleeds also increased during iCMP, possibly due to medication use (for example, steroids). Further multicenter studies of integrated care management programs are needed to confirm these findings.

SLE=systemic lupus erythematosus 1. Feldman CH et al. Development of a Set of Lupus-Specific, Ambulatory Care-Sensitive, Potentially Preventable Adverse Conditions: A Delphi Consensus Study. Arthritis Care Res (Hoboken). 2021; 73: 146-57.

*IR per 1000 person-years; IR=incidence rate; CI=confidence interval; Ref=reference; COPD=chronic obstructive pulmonary disease; all primary discharge diagnoses which were present in our data are presented above.

*IR per 1000 person-years; IR=incidence rate; CI=confidence interval; Ref=reference; all primary discharge diagnoses which were present in our data are presented above.


Disclosures: J. Williams, None; K. Taber, None; W. Huang, None; J. Collins, None; R. Cunningham, None; K. Concannon, None; C. Vogeli, None; L. Wichmann, None; C. Feldman, Pfizer Pharmaceuticals, 5.

To cite this abstract in AMA style:

Williams J, Taber K, Huang W, Collins J, Cunningham R, Concannon K, Vogeli C, Wichmann L, Feldman C. The Impact of an Integrated Care Management Program on Acute Care Use for Potentially Avoidable Conditions Among High-Risk Patients with SLE [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/the-impact-of-an-integrated-care-management-program-on-acute-care-use-for-potentially-avoidable-conditions-among-high-risk-patients-with-sle/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-impact-of-an-integrated-care-management-program-on-acute-care-use-for-potentially-avoidable-conditions-among-high-risk-patients-with-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology